Clinical trial of ketamine (ci-581): A preliminary report

  • S. A. Oduntan
  • R. Y. Gool


Ketamine (cI-581) is a derivative of phencyclidine. It produces analgesia and anaesthesia very rapidly, has a short duration of action, and is rapidly metabolized in the body. For this reason it has been used for continuous intravenous infusion or intermittent intravenous injections. It increases blood pressure and heart rate slightly. Respiration has not been found to be depressed during its use.

A report of the use of Ketamine in 100 consecutive patients is presented. Many of these patients were considered poor risks, and it is felt that Ketamine provided a greater margin of safety than conventional anaesthesia would have done. The dose used for induction was 1-1.25 mg/kg, while the maintenance dose was 1.5-2 mg/kg/hour.


Ketamine CANADIAN Anaesthetist Phencyclidine Cyclo Hexyl Amine Ketamine Anaesthesia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


La Kétamine (ci-581) est un dérivé de la phencyclidine. Elle produit ľanalgésie et ľanesthésie très rapidement, son action est de courte durée et elle est métabolisée rapidement. C’est pourquoi on ľa utilisé en perfusion veineuse continue ou en injections intraveineuses intermittentes. Elle produit une légère élévation de la pression sanguine et du rythme cardiaque. On n’a pas observé de dépression respiratoire pendant son utilisation.

On présente un rapport sur ľusage de la Kétamine pour 100 cas consécutifs. Plusieurs des malades étaient considérés comme de mauvais risques et il semble que la Kétamine a procuré une marge de sécurité supérieure à celle de ľanesthésie conventionnelle chez ces malades. La dose utilisée pour ľinduction a été de 1-1.25 mg/kg alors que la dose d'entretien a été de 1.5-2 mg/kg/heure.


  1. 1.
    Greifenstein, F. E.;Devault, M.;Yoshttake, J.; &Gajewsji, J. 1-Aryl Cyclo Hexyl Amine for Anesthesia. Anesth. & Analg.37: 283 (1958).Google Scholar
  2. 2.
    Gool, R. Y. &Clarke, H. L. Anaesthesia for Under-doctored Areas: A Trial of Phencyclidine in Nigeria. Anaesthesia.19: 265 (1964).PubMedCrossRefGoogle Scholar
  3. 3.
    Johnstone, M.;Evans, V.; &Baigel, S. Sernyl (ci-395) in Clinical Anaesthesia. Brit. J. Anaesth.31: 433 (1959).PubMedCrossRefGoogle Scholar
  4. 4.
    Muir, E. J.;Evans, V.; &Mulcahy, J. J. Sernyl Analgesia for Children’s Burn Dressing: A Preliminary Communication. Brit. J. Anaesth.33: 51 (1961).PubMedGoogle Scholar
  5. 5.
    Waddy, F. F. Phencyclidine. Anaesthesia.18: 117 (1963).CrossRefGoogle Scholar
  6. 6.
    Domino, E. F.;Chodoff, P.; &Corssen, G. Human Pharmacology of ci-581, a New Intravenous Agent Chemically Related to Phencyclidine. Fed. Proc.24: 268 (1965).Google Scholar
  7. 7.
    McCarthy, D. A.;Chen, G.;Kaump, D. H.; &Ensor, C. J. New Drugs.5: 21 (1965).Google Scholar
  8. 8.
    McCarthy, D. A. &Chen, G. General Anaesthetic Action of 2-(0-chlorophenyl)-2- methyl-aminocyclohexanone. Fed. Proc.24: 268 (1965).Google Scholar
  9. 9.
    Chen, G.;Glazko, A. J.; &Kaump, D. A Report from the Pharmacology Department, Parke Davis Research Laboratories (1965).Google Scholar
  10. 10.
    Corssen, G. &Domino, E. F. Dissociative Anaesthesia: Further Pharmacological Studies and First Clinical Experience with Phencyclidine Derivative ci-581. Anesth. & Analg.45: 29 (1966).CrossRefGoogle Scholar

Copyright information

© Canadian Anesthesiologists 1970

Authors and Affiliations

  • S. A. Oduntan
    • 1
  • R. Y. Gool
    • 1
  1. 1.Department of AnaesthesiaUniversity College HospitalIbadanNigeria

Personalised recommendations